BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Pharma Research

HitGen Announces Drug Discovery Research Agreement with ARase Therapeutics

HitGen will utilize its DNA-encoded library (DEL) technology platform, centered around the design, synthesis and screening of DELs, to identify novel inhib...

May 19, 2023 | News

Discovery Life Sciences Joins Akoya Biosciences' Global Network to Boost Immuno-Oncology Research

With this qualification, Discovery gains access to Akoya's PhenoImager® HT workflows, which can provide insights into the tumor microenvironment (...

May 19, 2023 | News

Asieris and UroViu Strengthen Partnership for Bladder Cancer Diagnosis and Treatment Platform

Under the agreement, Asieris Pharmaceuticals will use this patented technology in combination with specific optical imaging agents to conduct research on t...

May 19, 2023 | News

Australia's First End-to-End mRNA CDMO Facility to Boost Vaccine Production and Research Capabilities

What is the significance of the first end-to-end mRNA process contract development and manufacturing organization (CDMO) establishment in Australia? ...

May 17, 2023 | News

Hummingbird Bioscience, Merck to Evaluate HMBD-001 in Lung Carcinoma

Hummingbird Bioscience enters a clinical trial collaboration and supply agreement with Merck to evaluate HMBD-001, a potentially best-in-class anti-HER3 ...

May 16, 2023 | News

LaNova licenses novel cancer drug to AstraZeneca

LaNova Medicines Ltd. ("LaNova Medicines") announced it has entered into an exclusive license agreement with AstraZeneca (LSE/STO/Nasdaq: AZN), for LM-305,...

May 15, 2023 | News

Amgen and TScan collaborate to identify new Crohn's disease targets.

TScan to Receive $30 Million Upfront With Potential Development and Commercial Milestone Payments of Over $500 Million &nbs...

May 12, 2023 | News

Fujitsu partners with Takeda and National Cancer Center Japan to analyze and visualize ovarian cancer patient journey

Fujitsu today announced that it has conducted a joint research project with Takeda Pharmaceutical Company Limited and the National Cancer Center Japan to a...

May 12, 2023 | News

Nona Biosciences partners with PharmaEssentia Innovation Research Center

"We are pleased to enter this strategic collaboration with PharmaEssentia," Jingsong Wang, M.D., PhD, Chairman of Nona Biosciences, said, " PharmaEsse...

May 12, 2023 | News

CytoMed collaborates with MD Anderson to advance Gamma Delta T Cells in Oncology

CytoMed Therapeutics Limited (Nasdaq: GDTC) ("CytoMed" or the "Company"), a biopharmaceutical company focused on harnessing its licensed proprietary techno...

May 11, 2023 | News

Telix to Provide Illuccix® to Bayer for Global Phase III Prostate Cancer Study, Including Japan

This global study is investigating the efficacy of Bayer's androgen receptor inhibitor (ARi) darolutamide plus androgen deprivation therapy (ADT) versus AD...

May 08, 2023 | News

Cambridge Infinitus Research Centre Launches AI-based ERnet Platform for Cellular Health Studies.

With an impact factor of 47.99, Nature Methods is the world's leading international publication for biochemical research methodology. Upon public...

May 05, 2023 | News

Nouscom Reaches Clinical Phase II Using ProBioGen’s AGE1.CR.pIX® Production Platform

Nous-209 has been developed using the Nouscom's viral vector platform, which includes adenoviral and Modified Vaccinia Ankara (MVA) vectors, with MVA vecto...

May 04, 2023 | News

The Impact of Digital Health Technologies in Oncology: Current State and Future Directions

Digital health has revolutionized the way healthcare is delivered and managed in recent years. Oncology is one field that has benefited significantly from ...

May 03, 2023 | Opinion

Stay Connected